Skip to main content
Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.770
+0.010 (0.27%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Voyager Therapeutics Revenue

In the year 2025, Voyager Therapeutics had annual revenue of $40.37M, down -49.53%. Voyager Therapeutics had revenue of $15.34M in the quarter ending December 31, 2025, with 144.28% growth.

Revenue (ttm)
$40.37M
Revenue Growth
-49.53%
P/S Ratio
5.57
Revenue / Employee
$286,340
Employees
141
Market Cap
224.69M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202540.37M-39.63M-49.53%
Dec 31, 202480.00M-170.01M-68.00%
Dec 31, 2023250.01M209.10M511.16%
Dec 31, 202240.91M3.49M9.33%
Dec 31, 202137.42M-133.71M-78.14%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Keros Therapeutics 244.06M
Heron Therapeutics 154.90M
Fennec Pharmaceuticals 44.64M
Orchestra BioMed Holdings 33.48M
Camp4 Therapeutics 3.50M
Milestone Pharmaceuticals 1.55M
Artiva Biotherapeutics 251.00K
Revenue Rankings

VYGR News

More News